These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8023734)
1. Intensive diabetes treatment: a new deal for old people? Kerr D; Haigh R Age Ageing; 1994 Mar; 23(2):89-90. PubMed ID: 8023734 [No Abstract] [Full Text] [Related]
2. [Control of diabetes mellitus]. Daweke H Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437 [No Abstract] [Full Text] [Related]
3. Improvements in diabetes treatment. Zimmerman BR Minn Med; 1995 Apr; 78(4):46-8. PubMed ID: 7760785 [No Abstract] [Full Text] [Related]
4. [Insulin therapy of type I diabetes]. Willms B Wien Med Wochenschr; 1997; 147(9):206-10. PubMed ID: 9281233 [TBL] [Abstract][Full Text] [Related]
5. Intensified metabolic control in insulin-dependent diabetes mellitus. Dupre J Can Fam Physician; 1995 Jan; 41():12-4, 19-21. PubMed ID: 7894272 [No Abstract] [Full Text] [Related]
7. Innate and adaptive autoimmunity in type 1 diabetes. Morran MP; McInerney MF; Pietropaolo M Pediatr Diabetes; 2008 Apr; 9(2):152-61. PubMed ID: 18221432 [No Abstract] [Full Text] [Related]
8. Hepatic complications in poorly controlled type 1 diabetes mellitus: a case report. Martin J; Tomlinson P N Z Med J; 2014 Apr; 127(1392):95-7. PubMed ID: 24806252 [TBL] [Abstract][Full Text] [Related]
9. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group. Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395 [TBL] [Abstract][Full Text] [Related]
10. [Insulin therapy in patients with type 2 diabetes]. Siegmund T; Schumm-Draeger PM MMW Fortschr Med; 2008 May; 150(18):32-5; quiz 36. PubMed ID: 18533606 [No Abstract] [Full Text] [Related]
11. The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control. Hatz K; Minder AE; Lehmann R; Drescher T; Gerendas B; Schmidt-Erfurth U; Kaider A; Pruente C; Zulewski H Diabetes Res Clin Pract; 2019 Feb; 148():234-239. PubMed ID: 30684505 [TBL] [Abstract][Full Text] [Related]
12. Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump. Kuroda A; Yasuda T; Takahara M; Sakamoto F; Kasami R; Miyashita K; Yoshida S; Kondo E; Aihara K; Endo I; Matsuoka TA; Kaneto H; Matsumoto T; Shimomura I; Matsuhisa M Diabetes Technol Ther; 2012 Nov; 14(11):1077-80. PubMed ID: 23101953 [TBL] [Abstract][Full Text] [Related]
13. A naltrexone-induced increase in insulin requirement. Marrazzi MA; Jacober S; Luby ED J Clin Psychopharmacol; 1994 Oct; 14(5):363-5. PubMed ID: 7806698 [No Abstract] [Full Text] [Related]
14. Dose-response relationship of insulin glulisine in subjects with type 1 diabetes. Becker RH; Frick AD; Nosek L; Heinemann L; Rave K Diabetes Care; 2007 Oct; 30(10):2506-7. PubMed ID: 17675541 [No Abstract] [Full Text] [Related]
15. Glycaemia control in diabetes mellitus. Towards the normal profile? Zimmerman BR Drugs; 1994 Apr; 47(4):611-21. PubMed ID: 7516860 [TBL] [Abstract][Full Text] [Related]